Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

681 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C.
Bremova-Ertl T, Claassen J, Foltan T, Gascon-Bayarri J, Gissen P, Hahn A, Hassan A, Hennig A, Jones SA, Kolnikova M, Martakis K, Raethjen J, Ramaswami U, Sharma R, Schneider SA. Bremova-Ertl T, et al. Among authors: claassen j. J Neurol. 2022 Mar;269(3):1651-1662. doi: 10.1007/s00415-021-10717-0. Epub 2021 Aug 13. J Neurol. 2022. PMID: 34387740 Free PMC article. Clinical Trial.
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, Freilinger T, Neugebauer H, Spiegel R, Dichgans M, Lehmann-Horn F, Jurkat-Rott K, Brandt T, Jen JC, Jahn K. Strupp M, et al. Among authors: claassen j. Neurology. 2011 Jul 19;77(3):269-75. doi: 10.1212/WNL.0b013e318225ab07. Epub 2011 Jul 6. Neurology. 2011. PMID: 21734179 Free PMC article. Clinical Trial.
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
Feil K, Adrion C, Teufel J, Bösch S, Claassen J, Giordano I, Hengel H, Jacobi H, Klockgether T, Klopstock T, Nachbauer W, Schöls L, Stendel C, Uslar E, van de Warrenburg B, Berger I, Naumann I, Bayer O, Müller HH, Mansmann U, Strupp M. Feil K, et al. Among authors: claassen j. BMC Neurol. 2017 Jan 10;17(1):7. doi: 10.1186/s12883-016-0786-x. BMC Neurol. 2017. PMID: 28068987 Free PMC article. Clinical Trial.
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
Martakis K, Claassen J, Gascon-Bayari J, Goldschagg N, Hahn A, Hassan A, Hennig A, Jones S, Kay R, Lau H, Perlman S, Sharma R, Schneider S, Bremova-Ertl T. Martakis K, et al. Among authors: claassen j. Neurology. 2023 Mar 7;100(10):e1072-e1083. doi: 10.1212/WNL.0000000000201660. Epub 2022 Dec 1. Neurology. 2023. PMID: 36456200 Free PMC article. Clinical Trial.
A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, Bardins S, Rettinger N, Schneider E, Brandt T, Jahn K, Teufel J, Strupp M, Bronstein A. Claassen J, et al. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1392-9. doi: 10.1136/jnnp-2012-304736. Epub 2013 Jun 29. J Neurol Neurosurg Psychiatry. 2013. PMID: 23813743 Clinical Trial.
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
Feil K, Claaßen J, Bardins S, Teufel J, Krafczyk S, Schneider E, Schniepp R, Jahn K, Kalla R, Strupp M. Feil K, et al. Among authors: claassen j. Neurology. 2013 Sep 24;81(13):1152-8. doi: 10.1212/WNL.0b013e3182a55f6d. Epub 2013 Aug 23. Neurology. 2013. PMID: 23975871 Free article.
Adaptive motion processing in bilateral vestibular failure.
Kalla R, Muggleton N, Spiegel R, Bueti D, Claassen J, Walsh V, Bronstein A. Kalla R, et al. Among authors: claassen j. J Neurol Neurosurg Psychiatry. 2011 Nov;82(11):1212-6. doi: 10.1136/jnnp.2010.235960. Epub 2011 May 7. J Neurol Neurosurg Psychiatry. 2011. PMID: 21551468
681 results